| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/09/2005 | CN1188519C Fusion proteins comprising HIV-1 Tat and /or Nef proteins |
| 02/09/2005 | CN1188422C Calcium (3S) tetrahydro-3-furanyl (1S, 2R)-3-[[(4-aminophenyl)sulfonyl] (isobutyl) amino]-1-benzyl-2-(phosphonooxy) Propylcarbamate |
| 02/09/2005 | CN1188418C Cephalosporines having cyclic aminoguanidine substituents as antibiotics |
| 02/09/2005 | CN1188417C 3,6-disubstituted penam sulfone derivatives as antibacteriuls |
| 02/09/2005 | CN1188404C Cyclic compound |
| 02/09/2005 | CN1188403C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/09/2005 | CN1188258C Process for high polymer synthesis to phenol compounds and the use thereof |
| 02/09/2005 | CN1188172C G-CSF conjugates |
| 02/09/2005 | CN1188168C Vaccine compsn |
| 02/09/2005 | CN1188167C Method of controlling the qualities of attenuated pox vaccine |
| 02/09/2005 | CN1188162C Method for preparing Gongjinle medicinal liquor for treating tracheitis |
| 02/09/2005 | CN1188155C Bear gall pill of benefiting the liver |
| 02/09/2005 | CN1188145C Medicine for curing tuberculosis and preparing method |
| 02/09/2005 | CN1188143C Cold treating medicine |
| 02/09/2005 | CN1188142C Colera treating medicine |
| 02/09/2005 | CN1188132C Medicine for inhibiting and killing body's superficial pathogenic fungi |
| 02/09/2005 | CN1188125C Use of 2-imidazoly substituted carbinols for production of medicament for treatment or prophylaxis of disease states as result of ischaemic conditions |
| 02/09/2005 | CN1188122C 新制剂 The new formulation |
| 02/09/2005 | CN1188117C Application of 1, 3-diphenyl-1, 3-propanedione in preparing medicine for treating hepatitis |
| 02/09/2005 | CN1188111C Dry powder compositions having improved dispersivity |
| 02/08/2005 | US6852882 N-(2-(N-formyl-N-hydroxyamino)ethyl)arylamides with bacterial polypeptide deformylase inhibiting activity |
| 02/08/2005 | US6852861 Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via 1H-imidazo [4,5-C] quinolin-4-phthalimide intermediates |
| 02/08/2005 | US6852839 Fhm, a novel member of the TNF ligand supergene family |
| 02/08/2005 | US6852837 Nucleotide sequences coding protein for use in the treatment nflammatory bowel disease, sepsis, viral diseases and rheumatoid arthritis |
| 02/08/2005 | US6852756 Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases |
| 02/08/2005 | US6852751 Difluorobutyric acid metalloprotease inhibitors |
| 02/08/2005 | US6852749 Pyrazolidinol compounds |
| 02/08/2005 | US6852735 Novel siastatin B derivative having a potent inhibitory activity against a glycosidase, are now synthesized by new processes. The a potent enzyme inhibitory activity to a glycosidase, which is particularly N- |
| 02/08/2005 | US6852731 3-Substituted-7-oxo-4,7-dihydro-thieno(3,2-b)pyridine-6-carboxylic acid benzylamide derivatives; for herpes viruses |
| 02/08/2005 | US6852725 Imidazolyl derivatives |
| 02/08/2005 | US6852720 Thiazol-2-yl-imine compounds as PDE-7 inhibitors |
| 02/08/2005 | US6852711 HIV protease inhibitors |
| 02/08/2005 | US6852702 For treatment of bacterial infections |
| 02/08/2005 | US6852700 Colostrinin, and uses thereof |
| 02/08/2005 | US6852689 Methods for administration of antibiotics |
| 02/08/2005 | US6852522 Methods and interferon deficient substrates for the propagation of viruses |
| 02/08/2005 | US6852518 Glycosyl sulfotransferases GST-4α, GST-4β, and GST-6 |
| 02/08/2005 | US6852314 IFN-β liquid formulations |
| 02/08/2005 | US6852311 Ophthalmic ointments for treating infective eye disease |
| 02/08/2005 | CA2471102C Crystal form ii of clarithromycin |
| 02/08/2005 | CA2287316C Process for preparing 6-o-monoesters of castanospermine |
| 02/08/2005 | CA2130754C Amine derivatives of oxo- and hydroxy-substituted hydrocarbons |
| 02/08/2005 | CA2120001C Flavopereirine-based pharmaceutical composition and use thereof for treating hiv |
| 02/08/2005 | CA2096525C Retroviral protease inhibitors |
| 02/08/2005 | CA2096409C Retroviral protease inhibitors |
| 02/08/2005 | CA2096408C Retroviral protease inhibitors |
| 02/03/2005 | WO2005010169A2 High throughput or capillary-based screening for a bioactivity or biomolecule |
| 02/03/2005 | WO2005010154A2 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity |
| 02/03/2005 | WO2005010050A1 Hetero type pentamer recombinant vaccine |
| 02/03/2005 | WO2005010029A1 Aza-peptide macrocyclic hepatitis c serine protease inhibitors |
| 02/03/2005 | WO2005009959A1 Piperidine derivatives as ccr5 receptor modulators |
| 02/03/2005 | WO2005009480A2 Implants containing codrugs |
| 02/03/2005 | WO2005009473A1 Antifungal aerosol external preparation |
| 02/03/2005 | WO2005009463A2 Antigen-presenting cell vaccines and methods of use thereof |
| 02/03/2005 | WO2005009454A1 Periodontal disease therapeutic and/or preventive composition |
| 02/03/2005 | WO2005009451A1 Bacteriophage-containing therapeutic agents |
| 02/03/2005 | WO2005009449A1 Pharmaceutical active substance against warts, herpes simplex and herpes zoster |
| 02/03/2005 | WO2005009448A1 Treatment of lesions of the soft tissues |
| 02/03/2005 | WO2005009447A1 Single dose fast dissolving azithromycin |
| 02/03/2005 | WO2005009427A1 Curative medicine for allergosis |
| 02/03/2005 | WO2005009418A2 Purine nucleoside analogues for treating diseases caused by flaviviridae including hepatitis c |
| 02/03/2005 | WO2005009396A2 Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections |
| 02/03/2005 | WO2005009368A2 Antibiotic product, use and formulation thereof |
| 02/03/2005 | WO2005009365A2 Antibiotic product, use and formulation thereof |
| 02/03/2005 | WO2005009364A2 Antibiotic product, use and formulation thereof |
| 02/03/2005 | WO2005009343A2 A1 adenosine receptor antogonists |
| 02/03/2005 | WO2004054581A3 Cyclohexyl compounds as ccr5 antagonists |
| 02/03/2005 | WO2004002416A3 Methods and materials for treating human papillomavirus infections |
| 02/03/2005 | WO2002096360A3 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
| 02/03/2005 | US20050027119 Methyl (2S)-2-(2,3,4-trifluoroanilino)propionate from 2,3,4-trifluoroaniline and an acetic acid ester in the presence of a metal catalyst under a hydrogen gas; antibacterial agents |
| 02/03/2005 | US20050027009 New derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 02/03/2005 | US20050026997 Baccatin III analog containing a small peptide moiety; can be conjugated to cell binding agents; improved potency |
| 02/03/2005 | US20050026988 Cyclopenta'b! indole derivatives as spla inhibitors |
| 02/03/2005 | US20050026967 Inhibitors of c-jun N terminal kinases (JNK) and other protein kinases |
| 02/03/2005 | US20050026956 Carbinols for the treatment of neuropathic dysfunction |
| 02/03/2005 | US20050026943 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof |
| 02/03/2005 | US20050026942 Chemokine receptor binding heterocyclic compounds |
| 02/03/2005 | US20050026934 Dissolved in water; recrystallized, dehydrated; lymphadenopathy associated virus, human T-cell leukemia/lymphoma virus, hepatitis virus |
| 02/03/2005 | US20050026875 Treating bacterial, viral, or fungal infections, cancer, a lung injury, an eye disorder, neurological disorder or stroke |
| 02/03/2005 | US20050026863 Delivery of therapeutic gene products by intestinal cell expression |
| 02/03/2005 | US20050026858 Modified nucleotides for immunotherapy; induce immunology response; consisting of nucleoside methylphosphonate and 2'-O-methyl-ribonucleoside groups |
| 02/03/2005 | US20050026853 Anti-viral 7-deaza D-nucleosides and uses thereof |
| 02/03/2005 | US20050026851 Single dose fast dissolving azithromycin |
| 02/03/2005 | US20050026841 Hab18g/cd147 its antagonist and application |
| 02/03/2005 | US20050026820 reducing nephrotoxicity; increased therapeutic window for the glycopeptide to allow a greater amount to be administered |
| 02/03/2005 | US20050026819 Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent |
| 02/03/2005 | US20050026818 Cross-linked glycopeptide-cephalosporin antibiotics |
| 02/03/2005 | US20050026278 RNA interference mediating small RNA molecules |
| 02/03/2005 | US20050026251 Netrin receptor protein for use in identification of modulator for use in treatment and prevention of infection, nervous system, autoimmune, inflammatory, psycological and reproductive disorders |
| 02/03/2005 | US20050026214 Method of identifying glycosyl transferase binding compounds |
| 02/03/2005 | US20050025841 Therapeutic methods using herbal compositions |
| 02/03/2005 | US20050025815 Protonated/acidified nucleic acids are effective as bactericidal and/or bacteriostatic agents |
| 02/03/2005 | US20050025806 A silicone support of methylvinylsiloxane polymer including a fumed silca reinforcement filler; growth and/or reproduction-associated drug, derivative or analogue and carrier; each implant of insufficient size and/or payload for the predetermined threshold blood level of indicated drug; high-speed |
| 02/03/2005 | US20050025783 Vaccine |
| 02/03/2005 | US20050025775 Contacting a sample with an isolated monoclonal antibody that binds to a substantially-pure coagulase-negative Staphylococcus epidermidis capsular polyssocharide adhesin antigen that binds to polymeric material, wherein said adhesin antigen inhibits binding to polymeric material |
| 02/03/2005 | US20050025774 Such as N-(2-ethoxybenzyl)-5-hydroxy-1-methyl-2-(4-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide; for preventing, treating or delaying AIDS |
| 02/03/2005 | US20050025760 Pemphigus monoclonal antibody |
| 02/03/2005 | US20050025751 Increased or reduced expression of tumor necrosis factors or interleukins; antiinflammatory agents; autoimmune diseases |
| 02/03/2005 | US20050025747 Containing a priming and boosting composition, each with a non-replicating viral vector, with at least one of them being derived from a fowlpox virus; malaria, tuberculosis |
| 02/03/2005 | US20050025716 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract |